Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has submitted a compliance report to BSE regarding the re-lodgement of physical share transfer requests, as required by a SEBI circular dated July 2, 2025. The company publicized a special window for re-lodgement of physical share transfers through newspaper advertisements in Financial Express (English) and Nava Telangana (Telugu) on July 15, 2025 and September 15, 2025. For the month ended August 31, 2025, the registrar (Aarthi Consultants Limited) reported NIL requests received, processed, approved, or rejected, with no processing time recorded. The filing is purely a routine regulatory disclosure with no transaction activity during the period.
No material impact on shareholders or stock price. This is a standard compliance filing confirming that no physical share transfer re-lodgement requests were received during August 2025.